PALI
Palisade Bio Inc
NASDAQ: PALI · HEALTHCARE · BIOTECHNOLOGY
$2.00
+3.63% today
Updated 2026-04-30
Market cap
$328.54M
P/E ratio
—
P/S ratio
11.78x
EPS (TTM)
$-0.30
Dividend yield
—
52W range
$1 – $3
Volume
4.1M
Palisade Bio Inc (PALI) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-24.50%
ROA
-15.50%
Debt/equity
0.07x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | $265759.00 | $-3.15M | 100.00% | -1,189.80% | -1,184.16% |
| 2007 | $306057.00 | $-7.06M | 100.00% | -2,080.66% | -2,307.74% |
| 2008 | — | $-11.83M | — | — | — |
| 2009 | — | $-10.36M | — | — | — |
| 2010 | $733438.00 | $-18.39M | 100.00% | -2,070.39% | -2,506.96% |
| 2011 | $390625.00 | $-12.52M | 100.00% | -3,325.44% | -3,204.86% |
| 2012 | $407708.00 | $-10.12M | 100.00% | -2,491.00% | -2,482.66% |
| 2013 | $110000.00 | $-19.83M | 100.00% | -11,385.45% | -18,029.09% |
| 2014 | $18833.00 | $-22.63M | 100.00% | -92,582.17% | -120,156.11% |
| 2015 | $10417.00 | $-20.90M | 100.00% | -183,901.32% | -200,671.98% |
| 2016 | $16246.00 | $-21.07M | 100.00% | -124,135.17% | -129,724.24% |
| 2017 | $260000.00 | $-15.67M | 100.00% | -5,082.69% | -6,025.38% |
| 2018 | $260000.00 | $-4.92M | 480.77% | -3,176.54% | -1,894.23% |
| 2019 | $15394.00 | $-8.35M | 100.00% | -56,073.79% | -54,254.90% |
| 2020 | $13520.00 | $-10.32M | -1,079.88% | -68,764.79% | -76,346.15% |
| 2021 | $0.00 | $-26.62M | — | — | — |
| 2022 | $250000.00 | $-14.26M | -66.80% | -6,288.40% | -5,704.00% |
| 2023 | $250000.00 | $-12.30M | 100.00% | -5,228.00% | -4,920.00% |
| 2024 | $0.00 | $-14.44M | — | — | — |
| 2025 | $0.00 | $-16.78M | — | — | — |